Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

308.79

+6.07 (2.01%)

At close: Apr 23, 2025, 4:00 PM

301.20

-7.59 (-2.46%)

Pre-market: Apr 24, 2025, 4:05 AM EDT

Madrigal Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	180.13	-	-	-	-	Upgrade
Cost of Revenue	6.23	-	-	-	-	Upgrade
Gross Profit	173.9	-	-	-	-	Upgrade
Selling, General & Admin	435.06	108.15	48.13	37.32	21.86	Upgrade
Research & Development	236.72	272.35	245.44	205.16	184.81	Upgrade
Operating Expenses	671.78	380.5	293.57	242.48	206.67	Upgrade
Operating Income	-497.88	-380.5	-293.57	-242.48	-206.67	Upgrade
Interest Expense	-14.67	-12.71	-3.96	-	-	Upgrade
Interest & Investment Income	46.65	19.58	2.19	0.36	4.33	Upgrade
Other Non Operating Income (Expenses)	-	-	-	0.27	0.1	Upgrade
EBT Excluding Unusual Items	-465.89	-373.63	-295.35	-241.85	-202.24	Upgrade
Pretax Income	-465.89	-373.63	-295.35	-241.85	-202.24	Upgrade
Net Income	-465.89	-373.63	-295.35	-241.85	-202.24	Upgrade
Net Income to Common	-465.89	-373.63	-295.35	-241.85	-202.24	Upgrade
Shares Outstanding (Basic)	21	19	17	17	15	Upgrade
Shares Outstanding (Diluted)	21	19	17	17	15	Upgrade
Shares Change (YoY)	13.83%	9.05%	3.64%	7.05%	0.34%	Upgrade
EPS (Basic)	-21.90	-19.99	-17.23	-14.63	-13.09	Upgrade
EPS (Diluted)	-21.90	-19.99	-17.23	-14.63	-13.09	Upgrade
Free Cash Flow	-457.03	-325.71	-225.07	-184.13	-157.9	Upgrade
Free Cash Flow Per Share	-21.48	-17.43	-13.13	-11.13	-10.22	Upgrade
Gross Margin	96.54%	-	-	-	-	Upgrade
Operating Margin	-276.39%	-	-	-	-	Upgrade
Profit Margin	-258.64%	-	-	-	-	Upgrade
Free Cash Flow Margin	-253.72%	-	-	-	-	Upgrade
EBITDA	-496.78	-379.97	-293.1	-242.08	-206.2	Upgrade
EBITDA Margin	-275.78%	-	-	-	-	Upgrade
D&A For EBITDA	1.1	0.53	0.47	0.41	0.47	Upgrade
EBIT	-497.88	-380.5	-293.57	-242.48	-206.67	Upgrade
EBIT Margin	-276.39%	-	-	-	-	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q